Regenyx Medical


Develops peptide-based hydrogel biomaterials for soft tissue restoration and bone healing. Focus areas include integrating synthetic peptide hydrogels with autologous fat to create matrix-guided grafts, developing off-the-shelf soft tissue fillers, and composite regenerative bone grafts. Offers preclinical testing and engages surgeons and clinical leadership to advance investigational products.

Industries

N/A

Nr. of Employees

small (1-50)

Regenyx Medical

2 Bergman St. Rabin Science Park, Rehovot, Israel, 7670503


Products

Matrix-guided fat grafting formulation (hydrogel + autologous fat)

A formulation approach that mixes a synthetic peptide hydrogel with a patient’s autologous fat to form a matrix graft intended to improve fat graft survival and structural integrity.

Off-the-shelf soft tissue filler (hydrogel + collagen particles)

A pre-made soft tissue filler composed of synthetic hydrogel with collagen particle additives, developed for non-autologous soft tissue augmentation.

Composite regenerative bone graft (hydrogel + mineral scaffold)

A regenerative bone graft combining synthetic peptide hydrogel with allograft or synthetic mineral components to support natural bone healing processes.

Expertise Areas

  • Soft tissue restoration
  • Matrix-guided fat grafting
  • Biomaterials and peptide hydrogel engineering
  • Regenerative bone grafts
  • Show More (3)

Key Technologies

  • Synthetic peptide hydrogels
  • Hydrogel-mediated matrix grafting with autologous fat
  • Collagen-particle hydrogel formulations
  • Composite hydrogel-mineral bone grafts
  • Show More (1)

News & Updates

The matrix-guided fat-grafting product is currently unavailable for commercial use and is restricted to investigational purposes.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.